TLR Therapeutics

Wilmington, United States Founded: 2022 • Age: 4 yrs
Develops innovative therapeutics for treating myelodysplastic syndrome and gastric cancer.

About TLR Therapeutics

TLR Therapeutics is a Healthcare company based in Wilmington (United States) founded in 2022. It develops innovative therapeutics for treating myelodysplastic syndrome and gastric cancer. It operates on a B2B model. Its focus areas include Biotechnology, Therapeutics and Cancer Treatment. Its competitors include Intima Bioscience, Ilico Genetics and Kupffer Biotherapeutics; 1 of its 3 listed competitors has raised funding.

Company details

TLR Therapeutics, established in 2022, excels in providing healthcare solutions, advancing biotech innovations, therapeutics, and cancer treatment. Develops innovative therapeutics for treating myelodysplastic syndrome and gastric cancer. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

  • Headquarters Wilmington, United States
  • Sectors
    Healthcare
  • Website tlrtx.com

Competitors of TLR Therapeutics

TLR Therapeutics has 3 listed competitors in our database, 1 of them funded. They include Intima Bioscience, Ilico Genetics and Kupffer Biotherapeutics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
intimabioscience.com2014New York, United States
Therapeutics for gastrointestinal cancer are developed using CRISPR gene-editing.
ilicogenetics.com2020Bethlehem, United States$457,735
Developer of diagostic test for detection of gastric cancer
kupfferbio.com2019Burlingame, United States
Develops innovative technologies for anticancer therapies targeting gastrointestinal cancers.
Premium access

Detailed competitors of TLR Therapeutics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Immunology & Cancer Therapeutics

3 companies that operate in the same segment as TLR Therapeutics (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Targeted and immune-oncology drugs for cancer treatment are developed.
2010Cambridge, Massachusetts, United StatesUSD 172 M
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
2013San Francisco, California, United StatesUSD 214.78 MUSD 21.05 M211
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about TLR Therapeutics

TLR Therapeutics was founded in 2022.

TLR Therapeutics is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.

TLR Therapeutics, established in 2022, excels in providing healthcare solutions, advancing biotech innovations, therapeutics, and cancer treatment. Develops innovative therapeutics for treating myelodysplastic syndrome and gastric cancer. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

TLR Therapeutics's top competitors include Ilico Genetics, Intima Bioscience and Kupffer Biotherapeutics.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available